Kenneth Finn

Jan 16, 2025 | bottomlineinc.com | Kenneth Finn |Robert Michelin

As marijuana legalization continues to roll out, cannabis products are everywhere, including edibles such as cookies, brownies and gummies. Gummies in particular make the marijuana experience seem like child’s play. But there’s a lot you should know before jumping in, warns Ken Finn, MD, one of the founders of the International Academy on the Science and Impacts of Cannabis. CBD vs. THC.

Apr 8, 2024 | bottomlineinc.com | Kenneth Finn |Tom Cioffi

Medical marijuana is now available for purchase in 38 states, but thanks to lackluster regulation, buying dispensary marijuana remains a matter of “buyer beware.” Integrity issues. The content and potency of dispensary products are highly variable. Lack of controls. Budtenders (people who serve customers where marijuana is sold) aren’t required to have medical backgrounds.

Oct 25, 2023 | kevinmd.com | Gary Call |Rita Agarwal |Kenneth Finn

Subscribe to The Podcast by KevinMD. Catch up on old episodes!Join Richard A. Lawhern, a patient advocate. We delve into the critical issues surrounding U.S. policy for the regulation of prescription opioid pain relievers and the challenges faced by clinicians managing chronic pain patients. Explore the controversial CDC guidelines, the impact on both patients and medical professionals, and the need for evidence-based policymaking in this contentious field. Richard A. Lawhern is a patient advocate.

May 23, 2023 | kevinmd.com | Richard A. Lawhern |Amanda Xi |Kathleen A. Hallinan |Kenneth Finn

As a health care writer and policy analyst, I frequently encounter the term “risk” in discussions of medical issues. I also frequently see the term grossly misused in both the popular press and medical literature. Nowhere is this more evident than in the 2016 and 2022 CDC Guidelines for the prescription of opioids in the treatment of pain. In science, the term “incidence” is a measure of the likelihood that a defined outcome will occur.